Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NSPR InspireMD Inc New

-0.06 (-2.31%)
Last Updated: 12:11:42
Delayed by 15 minutes


Draw Mode:

Volume 16,507
Bid Price 2.50
Ask Price 2.53
News -
Day High 2.63


52 Week Range


Day Low 2.54
Company Name Stock Ticker Symbol Market Type
InspireMD Inc New NSPR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.06 -2.31% 2.54 12:11:42
Open Price Low Price High Price Close Price Prev Close
2.61 2.54 2.63 2.60
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
53 16,507 $ 2.60 $ 42,879 - 1.81 - 3.85
Last Trade Time Type Quantity Stock Price Currency
12:08:49 100 $ 2.54 USD

InspireMD Inc New Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
57.7M 23.46M - 6.21M -19.92M -0.85 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

InspireMD News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No NSPR Message Board. Create One! See More Posts on NSPR Message Board See More Message Board Posts

Historical NSPR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.662.742.462.6411,879-0.12-4.51%
1 Month2.292.782.182.5815,7400.2510.92%
3 Months2.332.781.812.2534,0180.219.01%
6 Months2.313.241.812.4432,0320.239.96%
1 Year1.853.851.812.8547,0520.6937.30%
3 Years5.966.820.80643.8997,719-3.42-57.38%
5 Years5.126.820.80643.96100,486-2.58-50.39%

InspireMD Description

InspireMD Inc is the United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.

Your Recent History

Delayed Upgrade Clock